LaRochelle Karen
- SEC CIK
- 0001822915
No open-market purchases or sales filed in the past year.
Current role at each company
- PXMD Kuvatris Therapeutics, Inc.Directoras of Mar 14, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists LaRochelle Karen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 (view filing)5:19 PM ET | Jan 29 | 2 days | LaRochelle KarenDirector | SSale | −78 | $0.48 | −$37.44 | −2.7%2.83K after | |
| Nov 29, 2023 (view filing) | Nov 27 | 2 days | LaRochelle KarenDirector | SSale | −35 | $1.03 | −$36.05 | −1.2%2.91K after | 10b5-1 |
| Oct 30, 2023 (view filing)4:12 PM ET | Oct 27 | 3 days | LaRochelle KarenDirector | SSale | −1.68K | $0.189 | −$317.33 | −3.2%50.0K after | 10b5-1 |
| Aug 30, 2023 (view filing)4:09 PM ET | Aug 28-29 | 2 days | LaRochelle KarenDirector | SSale | −2.46K | $0.4979 | −$1.22K | −4.5%51.7K after | 2 lots10b5-1 |
| Mar 9, 2023 (view filing) | Mar 9 | Same day | LaRochelle KarenDirector | SSale | −335 | $1.48 | −$495.8 | −0.8%42.4K after | |
| Mar 3, 2023 (view filing) | Mar 2-3 | 1 day | LaRochelle KarenDirector | SSale | −8.83K | $1.94 | −$17.1K | −17.1%42.8K after | 2 lots |